sees clear need new drugs type data help prioritize candidate drug targets discovery step direction personalized medicine looking genetic profiles able tell appropriate therapy person says study co author robert baldassano director center pediatric inflammatory bowel disease children hospital genetic tests day indicate patients predisposed high levels possibly associated newly identified receptor gene variant helping identify patients respond therapy stefan schreiber director clinical molecular biology christian albrechts university kiel germany believes study mandate revamping development effective disease look physicians treating children adults underlying genetics clearly different schreiber says researchers not anticipate children react therapy like adults ultimately study goes adding